XML 26 R11.htm IDEA: XBRL DOCUMENT v3.25.1
Cash, Cash Equivalents and Restricted Cash
3 Months Ended
Mar. 31, 2025
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents and Restricted Cash Cash, Cash Equivalents and Restricted Cash
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts shown in the Condensed Consolidated Statements of Cash Flows:
(in thousands)As of March 31,
2025
As of December 31,
2024
Cash and cash equivalents available for general corporate purposes$64,229 $265,647 
Joint venture cash and cash equivalents212,260 189,437 
Cash and cash equivalents276,489 455,084 
Restricted cash40,296 9,104 
Total cash, cash equivalents and restricted cash$316,785 $464,188 
Cash equivalents include short-term, highly liquid investments with maturities of three months or less when acquired. Cash and cash equivalents consist of amounts available for the Company’s general purposes, the Company’s proportionate share of cash held by the Company’s unconsolidated joint ventures and 100% of amounts held by the Company’s consolidated joint ventures. In both cases, cash held by joint ventures is available only for joint venture-related uses, including future distributions to joint venture partners.
Restricted cash includes amounts primarily held as collateral to secure insurance-related contingent obligations, such as insurance claim deductibles, in lieu of letters of credit.